Page last updated: 2024-08-17

cycloheximide and Cancer of Head

cycloheximide has been researched along with Cancer of Head in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Cui, L; Guo, B; Ran, W; Shu, D; Si, S; Sun, W; Zhao, X1
Kim, EH; Park, HB; Park, JY; Roh, JL1
Chen, ZG; Haque, A; Khuri, FR; Rahman, MA; Ruhul Amin, AR; Saba, NF; Shin, DM1
Hasselbalch, B; Lassen, U; Poulsen, HS; Stockhausen, MT1
Ishida, K; Osada, H; Sato, TA; Simizu, S; Wierzba, MK1
Dimitroulakos, J; Goss, G; Lorimer, IA; Mantha, AJ; McFee, KE; Niknejad, N1
Johnson, JT; Sung, MW; Van Dongen, G; Whiteside, TL1
Byun, Y; Carey, TE; Choi, JH; Chung, JW; Han, IS; Kim, SH; Kim, SY; Lee, HR; Lee, KS; Yu, HK1

Other Studies

8 other study(ies) available for cycloheximide and Cancer of Head

ArticleYear
PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Cancer communications (London, England), 2022, Volume: 42, Issue:10

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cycloheximide; F-Box-WD Repeat-Containing Protein 7; Feedback; Head and Neck Neoplasms; Humans; Membrane Proteins; Mice; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction; Squamous Cell Carcinoma of Head and Neck

2022
The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer.
    Cell death & disease, 2013, Dec-12, Volume: 4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Cell Line; Cisplatin; Cycloheximide; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Male; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2013
Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2.
    Apoptosis : an international journal on programmed cell death, 2015, Volume: 20, Issue:7

    Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Catechin; Cell Line, Tumor; Cycloheximide; Drug Synergism; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Head and Neck Neoplasms; Humans; Membrane Proteins; Phosphorylation; Protein Biosynthesis; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; RNA Interference

2015
Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling.
    Cancer investigation, 2010, Volume: 28, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Survival; Cetuximab; Cycloheximide; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Gene Amplification; Gene Expression Regulation, Neoplastic; Glioma; Head and Neck Neoplasms; Humans; Phosphorylation; Signal Transduction

2010
Expression of heparanase in human tumor cell lines and human head and neck tumors.
    Cancer letters, 2003, Apr-10, Volume: 193, Issue:1

    Topics: Blotting, Western; Cycloheximide; DNA Methylation; Glucuronidase; Head and Neck Neoplasms; HeLa Cells; Humans; Neoplasm Invasiveness; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Tumor Cells, Cultured

2003
Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.
    Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cycloheximide; Dactinomycin; Drug Delivery Systems; ErbB Receptors; Head and Neck Neoplasms; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Protein-Tyrosine Kinases

2003
Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    International journal of cancer, 1996, May-03, Volume: 66, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Carcinoma, Squamous Cell; Cell Line; Cycloheximide; Dactinomycin; Flow Cytometry; Head and Neck Neoplasms; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Killer Cells, Natural; Mice; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996
The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines.
    Metabolism: clinical and experimental, 1998, Volume: 47, Issue:8

    Topics: Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Cycloheximide; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dactinomycin; Enzyme Induction; Head and Neck Neoplasms; Humans; Ketoconazole; Oxidation-Reduction; Protein Synthesis Inhibitors; Retinoids; Tretinoin; Tumor Cells, Cultured

1998